The Association between Metabolic Syndrome and Epithelial Cell Abnormalities Detected on Pap Smear: A Nationwide Population-Based Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Database Population
2.2. Statistical Analysis
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- Health Insurance Review & Assessment Service. National Interest Disease Statistics. Available online: http://opendata.hira.or.kr/op/opc/olapMfrnIntrsIlnsInfo.do (accessed on 20 February 2023).
- Ha, H.I.; Chang, H.K.; Park, S.J.; Lim, J.; Won, Y.J.; Lim, M.C. The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry. Obstet. Gynecol. Sci. 2021, 64, 444–453. [Google Scholar] [CrossRef] [PubMed]
- Ghalavandi, S.; Heidarnia, A.; Zarei, F.; Beiranvand, R. Knowledge, attitude, practice, and self-efficacy of women regarding cervical cancer screening. Obstet. Gynecol. Sci. 2021, 64, 216–225. [Google Scholar] [CrossRef] [PubMed]
- Schiffman, M.; Wentzensen, N.; Wacholder, S.; Kinney, W.; Gage, J.C.; Castle, P.E. Human papillomavirus testing in the prevention of cervical cancer. J. Natl. Cancer Inst. 2011, 103, 368–383. [Google Scholar] [CrossRef]
- Rodríguez, A.C.; Schiffman, M.; Herrero, R.; Hildesheim, A.; Bratti, C.; Sherman, M.E.; Solomon, D.; Guillén, D.; Alfaro, M.; Morales, J.; et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: Critical role of duration of infection. J. Natl. Cancer Inst. 2010, 102, 315–324. [Google Scholar] [CrossRef]
- Haffner, S.M.; Valdez, R.A.; Hazuda, H.P.; Mitchell, B.D.; Morales, P.A.; Stern, M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992, 41, 715–722. [Google Scholar] [CrossRef]
- Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120, 1640–1645. [Google Scholar] [CrossRef]
- Cowey, S.; Hardy, R.W. The metabolic syndrome: A high-risk state for cancer? Am. J. Pathol. 2006, 169, 1505–1522. [Google Scholar] [CrossRef]
- Lee, D.Y.; Lee, T.S. Associations between metabolic syndrome and gynecologic cancer. Obstet. Gynecol. Sci. 2020, 63, 215–224. [Google Scholar] [CrossRef]
- Ulmer, H.; Bjørge, T.; Concin, H.; Lukanova, A.; Manjer, J.; Hallmans, G.; Borena, W.; Häggström, C.; Engeland, A.; Almquist, M.; et al. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me–Can). Gynecol. Oncol. 2012, 125, 330–335. [Google Scholar] [CrossRef]
- Penaranda, E.K.; Shokar, N.; Ortiz, M. Relationship between metabolic syndrome and history of cervical cancer among a US national population. Int. Sch. Res. Not. 2013, 2013, 840964. [Google Scholar] [CrossRef] [PubMed]
- Song, S.O.; Jung, C.H.; Song, Y.D.; Park, C.Y.; Kwon, H.S.; Cha, B.S.; Park, J.Y.; Lee, K.U.; Ko, K.S.; Lee, B.W. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab. J. 2014, 38, 395–403. [Google Scholar] [CrossRef] [PubMed]
- Park, H.S.; Park, C.Y.; Oh, S.W.; Yoo, H.J. Prevalence of obesity and metabolic syndrome in Korean adults. Obes. Rev. 2008, 9, 104–107. [Google Scholar] [CrossRef] [PubMed]
- Sullican, G.M.; Feinn, R. Using Effect Size—Or Why the P Value Is Not Enough. J. Grad. Med. Educ. 2012, 4, 279–282. [Google Scholar] [CrossRef] [PubMed]
- Huang, X.; Zhao, Q.; Yang, P.; Li, Y.; Yuan, H.; Wu, L.; Chen, Z. Metabolic syndrome and risk of cervical human papillomavirus incident and persistent infection. Medicine 2016, 95, e2905. [Google Scholar] [CrossRef]
- Molokwu, J.C.; Penaranda, E.; Lopez, D.S.; Dwivedi, A.; Dodoo, C.; Shokar, N. Association of Metabolic Syndrome and Human Papillomavirus Infection in Men and Women Residing in the United States. Cancer Epidemiol. Biomark. Prev. 2017, 26, 1321–1327. [Google Scholar] [CrossRef]
- Lee, S.W.; Cho, H.H.; Kim, M.R.; Kwon, D.J.; Jung, E.; You, Y.O.; Kim, J.H. The relationship between serum leptin level and metabolic syndrome in postmenopausal women. Korean J. Obstet. Gynecol. 2010, 53, 254–263. [Google Scholar] [CrossRef]
- Van Kruijsdijk, R.C.; Van Der Wall, E.; Visseren, F.L. Obesity and Cancer: The Role of Dysfunctional Adipose Tissue Obesity and Cancer. Cancer Epidemiol. Biomark. Prev. 2009, 18, 2569–2578. [Google Scholar] [CrossRef] [PubMed]
- Iyengar, N.M.; Gucalp, A.; Dannenberg, A.J.; Hudis, C.A. Obesity and cancer mechanisms: Tumor microenvironment and inflammation. J. Clin. Oncol. 2016, 34, 4270–4276. [Google Scholar] [CrossRef]
- Macheda, M.L.; Rogers, S.; Best, J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell Physiol. 2005, 202, 654–662. [Google Scholar] [CrossRef]
- Iwatsuki, M.; Mimori, K.; Yokobori, T.; Ishi, H.; Beppu, T.; Nakamori, S.; Baba, H.; Mori, M. Epithelial–mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010, 101, 293–299. [Google Scholar] [CrossRef] [PubMed]
- Jung, M. Risk factors of sexually transmitted infections among female sex workers in Republic of Korea. Infect. Dis. Poverty 2019, 8, 6. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Cases (n = 580,012) | Controls (n = 8,606,394) | p Value | OR |
---|---|---|---|---|
Age (mean ± SD, years) | 54.3 ± 10.4 | 50.9 ± 9.9 | <0.0001 | |
Age ≥ 40 years | 94.2 | 91.9 | <0.0001 | 1.43 |
Components of metabolic syndrome | ||||
Waist circumference ≥ 85 cm | 19.5 | 18.1 | <0.0001 | 1.10 |
Hypertension | 40.5 | 34.2 | <0.0001 | 1.31 |
Hypertriglyceridemia | 20.3 | 18.5 | <0.0001 | 1.12 |
Low HDL cholesterol | 34.1 | 31.2 | <0.0001 | 1.14 |
Hyperglycemia | 31.3 | 28.8 | <0.0001 | 1.13 |
Metabolic syndrome (≥3 components) | 21.7 | 18.4 | <0.0001 | 1.23 |
Alcohol intake | 9.1 | 11.0 | <0.0001 | 0.81 |
Smoking status | <0.0001 | 0.85 * | ||
Never-smoker | 95.1 | 94.3 | ||
Ex-smoker | 2.0 | 2.2 | ||
Current smoker | 2.9 | 3.5 |
Univariate Model | |||
---|---|---|---|
OR | 95% CI | p Value | |
Metabolic syndrome (≥3 components) | 1.23 | 1.22, 1.24 | <0.0001 |
5 components vs. no components | 1.37 | 1.34, 1.39 | <0.0001 |
4 components vs. no components | 1.40 | 1.39, 1.42 | <0.0001 |
3 components vs. no components | 1.36 | 1.35, 1.37 | <0.0001 |
2 components vs. no components | 1.28 | 1.27, 1.29 | <0.0001 |
1 component vs. no components | 1.14 | 1.13, 1.15 | <0.0001 |
Waist circumference ≥85 cm | 1.10 | 1.09, 1.10 | <0.0001 |
Hypertension | 1.31 | 1.30, 1.32 | <0.0001 |
Hypertriglyceridemia | 1.12 | 1.11, 1.13 | <0.0001 |
Low HDL | 1.14 | 1.13, 1.15 | <0.0001 |
Hyperglycemia | 1.13 | 1.12, 1.13 | <0.0001 |
Multivariate Model | |||
---|---|---|---|
AOR | 95% CI | p Value | |
Age ≥ 40 years | 1.37 | 1.35, 1.38 | |
Metabolic syndrome (≥3 components) | 1.20 | 1.20, 1.21 | <0.0001 |
Alcohol intake | 0.86 | 0.85, 0.87 | <0.0001 |
Smoking (Smoker vs. never-smoker) | 0.88 | 0.87, 0.90 | <0.0001 |
(Ex-smoker vs. never-smoker) | 0.93 | 0.91, 0.95 | <0.0001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, D.; Lee, T.S. The Association between Metabolic Syndrome and Epithelial Cell Abnormalities Detected on Pap Smear: A Nationwide Population-Based Study. J. Clin. Med. 2023, 12, 2954. https://doi.org/10.3390/jcm12082954
Lee D, Lee TS. The Association between Metabolic Syndrome and Epithelial Cell Abnormalities Detected on Pap Smear: A Nationwide Population-Based Study. Journal of Clinical Medicine. 2023; 12(8):2954. https://doi.org/10.3390/jcm12082954
Chicago/Turabian StyleLee, Dayong, and Taek Sang Lee. 2023. "The Association between Metabolic Syndrome and Epithelial Cell Abnormalities Detected on Pap Smear: A Nationwide Population-Based Study" Journal of Clinical Medicine 12, no. 8: 2954. https://doi.org/10.3390/jcm12082954